Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept for Failing Renal Allograft
NCT01921218Phase 3Completed
- Start
- Aug 2013
- Primary completion
- Dec 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of belatacept in kidney transplant rejection. Started Aug 2013; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01921218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921218.